Trial · NCT07908407
Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial
NCT07908407, Not applicable, Not yet recruiting, Fred Hutchinson Cancer Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial. Trials, record NCT07908407. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908407
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial
- NCT number
- NCT07908407
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Fred Hutchinson Cancer Center
- Conditions
- Bladder Carcinoma, Prostate Carcinoma
- Interventions
- Electronic Health Record Review, Patient Navigation, Prescreen, Rescreening, Survey Administration
- First posted
- 2026-11-02
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of patients who "agree" or "completely agree" in the Feasibility of Intervention Measure (Feasibility) | After pre-screening for clinical trials is complete (Up to 9 months) | |
| Primary | Percentage of community providers who "agree" or "completely agree" in the Feasibility of Intervention Measure (Feasibility) | After enrollment is complete at the end of study period (Up to 24 months) | |
| Primary | Percentage of patients who "agree" or "completely agree" in the Acceptability of Intervention Measure (Acceptability) | After pre-screening for clinical trials is complete (Up to 9 months) | |
| Primary | Percentage of community providers who "agree" or "completely agree" in the Acceptability of Intervention Measure (Acceptability) | After enrollment is complete at the end of study period (Up to 24 months) | |
| Primary | Percentage of patients who "agree" or "completely agree" in the Intervention Appropriateness Measure (Appropriateness) | After pre-screening for clinical trials is complete (Up to 9 months) | |
| Primary | Percentage of community providers who "agree" or "completely agree" in the Intervention Appropriateness Measure (Appropriateness) | After enrollment is complete at the end of study period (Up to 24 months) | |
| Primary | Percentage of remotely screened patients that are identified as eligible for a prostate or bladder cancer clinical trial at Fred Hutch (FH) and enroll in that clinical trial | Up to 9 months | Analysis of these percentages will be taken into context with the reported barriers that our patient population describes. Will provide rationale for a larger clinical trial, in which barriers can be directly addressed if possible, to assess improvement in clinical trial interest/participation among patients receiving care in the community. |
| Primary | Percentage of remotely screened patients that are identified as eligible or potentially eligible for a prostate or bladder cancer clinical trial at FH, and express interest in participating | Up to 9 months | Analysis of these percentages will be taken into context with the reported barriers that our patient population describes. Will provide rationale for a larger clinical trial, in which barriers can be directly addressed if possible, to assess improvement in clinical trial interest/participation among patients receiving care in the community. |
| Secondary | Perceived barriers to participation in clinical trials | Baseline up to 9 months | Free-text survey data from patients and qualitative interview data from referring providers will be analyzed using Braun \& Clarke's inductive thematic analysis framework. |
| Secondary | Distribution of participants by race and ethnicity among remotely pre-screened patients who enroll or indicate intent to enroll in a clinical trial | Up to 9 months | Free-text survey data from patients and qualitative interview data from referring providers will be analyzed using Braun \& Clarke's inductive thematic analysis framework. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| P30CA015704 | Cancer Center Support Grant | LYNCH, THOMAS JAMES | FRED HUTCHINSON CANCER CENTER | NATIONAL CANCER INSTITUTE | 1985 to 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908407
GET https://conductscience.org/api/trials/v1/NCT07908407/registered